Myosin-Specific Adaptations of In vitro Fluorescence Microscopy-Based Motility Assays
February 4th, 2021
5.6K views
Presented here is a procedure to express and purify myosin 5a followed by a discussion of its characterization, using both ensemble and single molecule in vitro fluorescence microscopy-based assays, and how these methods can be modified for the characterization of nonmuscle myosin 2b.
Overview
This protocol details the expression and purification of myosin 5a, followed by its characterization using in vitro fluorescence microscopy assays. It also discusses modifications for studying non-muscle myosin 2b.
Key Study Components
Area of Science
- Biochemistry
- Cell Biology
- Neuroscience
Background
- Myosins play critical roles in cellular motility.
- Understanding myosin dynamics is essential for elucidating their functions in cells.
- Non-muscle myosins are involved in various cellular processes.
- Characterization techniques can reveal the impact of mutations on myosin behavior.
Purpose of Study
- To characterize non-muscle myosin dynamics at the protein level.
- To inform on the motile properties contributing to cellular roles.
- To investigate the effects of regulatory conditions on myosin motility.
Methods Used
- Ensemble and single molecule fluorescence microscopy.
- Characterization of purified myosins.
- Optimization of fluorophores and chemical conditions.
- Setup and coating of flow chambers for experiments.
Main Results
- The protocol is fast, reproducible, and highly controlled.
- It allows for the study of disease-causing mutations in non-muscle myosins.
- Versatile methodology applicable to other cytoskeletal systems.
- Quick optimization for various experimental conditions.
Conclusions
- Understanding myosin dynamics enhances knowledge of cellular behaviors.
- This method provides a strong foundation for future studies.
- It raises important questions regarding myosin function in health and disease.
Frequently Asked Questions
What is the significance of myosin 5a?
Myosin 5a is crucial for cellular motility and transport processes.
How can this protocol be adapted for other myosins?
The methodology can be modified for various myosins by adjusting conditions and assays.
What are the advantages of using fluorescence microscopy?
Fluorescence microscopy allows for detailed observation of molecular dynamics at both ensemble and single molecule levels.
Can this method be used to study myosin mutations?
Yes, it is designed to investigate how mutations affect myosin behavior.
What are flow chambers used for in this protocol?
Flow chambers facilitate controlled experimental conditions for studying myosin interactions.
Is this protocol suitable for high-throughput studies?
The method's reproducibility and control make it suitable for high-throughput applications.
Executive Industry Relevance
This protocol enables quantitative characterization of myosin motility at single molecule and ensemble levels, providing mechanistic insights into motor protein function. It supports target validation by linking biochemical properties to cellular phenotypes, informing de-risking of myosin-directed therapeutic strategies. The approach is adaptable to disease-relevant models, facilitating preclinical evaluation of myosin isoform dynamics under controlled conditions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of myosin mechanochemistry to clarify functional roles in cellular transport and adhesion.
- Operational Value: Provides reproducible, quantitative readouts of translocation velocity and run length for target engagement assessment.
- Predictive Value: Supports hypothesis testing of how regulatory conditions or mutations alter motor protein behavior, aiding in target confidence scoring.
Screening & Assay Development
- Assay Readiness: Generates standardized, fluorescence-based motility assays compatible with high-content imaging for compound screening.
- Quantitative Output: Delivers measurable parameters such as actin translocation velocity and single molecule run length for dose-response analysis.
- Platform Reuse: Adaptable to other cytoskeletal systems (e.g., kinesin/dynein with microtubules), enabling cross-target assay portability.
Translational & Preclinical Research
- Disease Modeling: Allows reconstitution of cellular conditions to study disease-causing mutations in non-muscle myosins at the protein level.
- Mechanistic De-risking: Links molecular motility defects to cellular phenotypes, supporting translational biomarker alignment.
- Preclinical Continuity: Bridges discovery-stage target validation with preclinical functional assessment through conserved assay format.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to lead optimization, offering biophysical characterization that informs structure-function relationships in motor proteins.
- Discovery Biology: Supports pathway clarification and functional validation of myosin isoforms through direct observation of motility dynamics.
- Screening: Enables assay standardization and reproducibility for evaluating compound effects on motor protein activity under controlled buffer conditions.
- Analytics: Provides quantitative measurements of velocity and processivity that allow comparison across isoforms, mutants, or treatment conditions.
- Translational Research: Connects single molecule behavior to ensemble-level outputs relevant to cellular functions like cytokinesis and tension maintenance.
- Enterprise Reuse: Establishes a reusable platform for studying diverse motor proteins across therapeutic areas, reducing assay redevelopment effort.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing ambiguity in myosin mechanochemical coupling.
- Operational Value: Ensures assay reproducibility and standardization across laboratories through defined flow chamber preparation and imaging protocols.
- Strategic Value: Improves go/no-go decisions by enabling early detection of motility-altering mutations or regulatory effects.
- Portfolio Impact: Facilitates risk-adjusted prioritization of myosin targets based on validated functional domains and motility profiles.
Implementation Considerations
- Requires expertise in protein purification, fluorescence microscopy, and image analysis for motility tracking.
- Depends on access to TIRF or widefield fluorescence microscopy systems and flow chamber fabrication capabilities.
- Necessitates standardization of buffer conditions, ATP concentrations, and fluorophore selection across experimental replicates.
- Involves optimization considerations for different myosin isoforms regarding surface density, ionic strength, and regulatory protein inclusion.
- Limited by the need for purified, functional protein preparations; activity may be affected by tags, degradation, or improper folding.
Biopharma FAQs
Why does velocity measurement matter for myosin target validation?
Quantifying actin translocation velocity provides a functional readout of myosin mechanochemical activity, enabling comparison between wild-type and mutant isoforms to assess target engagement and functional impact.
How does isolating the myosin variable support discovery pipeline decisions?
By immobilizing myosin on a surface and controlling actin and ATP conditions, the assay isolates myosin-driven motility, allowing unambiguous attribution of observed effects to the target protein under study.
What do single molecule run length measurements enable in preclinical assessment?
Run length measurements reveal the processivity of myosin molecules, indicating how far they travel along actin before detaching, which informs predictions about cellular transport efficiency and force generation.
Why are replication requirements important for cross-functional collaboration?
Replicate measurements ensure data reliability and reproducibility across teams, supporting consistent interpretation of motility data in target validation and lead optimization workflows.
What statistical analysis is needed before implementing this assay in screening?
Implementation requires baseline characterization, variance assessment, and threshold setting for hit selection, enabling robust Z'-factor or similar metric calculations for assay quality control.
